Rehill AM, Leon G, McCluskey S, Schoen I, Hernandez-Santana Y, Annett S, Klavina P, Robson T, Curtis AM, Renné T, Hussey S, O'Donnell JS, Walsh PT, Preston RJS, 2023 Oct 20, Glycolytic reprogramming fuels myeloid cell-driven hypercoagulability. J Thromb Haemost, DOI: 10.1016/j.jtha.2023.10.006 |
Valke LLFG, Verhagen MJA, Mulders BTPM, Polenewen R, Blijlevens NMA, Jansen JH, Mansouritorghabeh H, Elsheikh E, Reipert BM, Turecek PL, O'Donnell JS, Rijpma SR, Schols SEM, van Heerde WL, Meijer D, 2023 Nov, The Nijmegen ultra-sensitive Bethesda Assay detects very low-titer factor VIII inhibitors in patients with congenital and acquired hemophilia A. Thromb Res, DOI: 10.1016/j.thromres.2023.10.007 |
Fogarty H, Ahmad A, Atiq F, Doherty D, Ward S, Karampini E, Rehill A, Leon G, Byrne C, Geoghegan R, Conroy H, Byrne M, Budde U, Schneppenheim S, Sheehan C, Ngwenya N, Baker RI, Preston RJS, Tuohy E, McMahon C, O'Donnell JS, 2023 Nov 28, VWF-ADAMTS13 axis dysfunction in children with sickle cell disease treated with hydroxycarbamide vs blood transfusion. Blood Adv, DOI: 10.1182/bloodadvances.2023010824 |
Ridge K, Fogarty H, Doherty D, Byrne M, O'Farrelly C, O'Donnell JS, Conlon N, 2023 Jul, Enhanced thrombin generation potential and endothelial dysfunction in chronic spontaneous urticaria. Clin Transl Allergy, DOI: 10.1002/clt2.12285 |
Ryan TAJ, Hooftman A, Rehill AM, Johansen MD, O' Brien EC, Toller-Kawahisa JE, Wilk MM, Day EA, Weiss HJ, Sarvari P, Vozza EG, Schramm F, Peace CG, Zotta A, Miemczyk S, Nalkurthi C, Hansbro NG, McManus G, O'Doherty L, Gargan S, Long A, Dunne J, Cheallaigh CN, Conlon N, Carty M, Fallon PG, Mills KHG, Creagh EM, O' Donnell JS, Hertzog PJ, Hansbro PM, McLoughlin RM, Wygrecka M, Preston RJS, Zasłona Z, O'Neill LAJ, 2023 Jul 20, Publisher Correction: Dimethyl fumarate and 4-octyl itaconate are anticoagulants that suppress Tissue Factor in macrophages via inhibition of Type I Interferon. Nat Commun, DOI: 10.1038/s41467-023-40034-1 |
O'Donnell JS, Fleming H, Noone D, Preston RJS, 2023 Dec, Unraveling coagulation factor-mediated cellular signaling. J Thromb Haemost, DOI: 10.1016/j.jtha.2023.06.019 |
Comerford C, Dhami SPS, Murphy P, Patmore S, Ward S, Pushkar N, Budde U, Karampini E, O'Donnell JS, Glavey S, Quinn J, O'Sullivan JM, 2023 Jun, Elevated von Willebrand factor levels in multiple myeloma: dysregulated mechanisms of both secretion and clearance. Thromb Res, DOI: 10.1016/j.thromres.2023.04.014 |
Kennedy M, Roche S, McGowan M, Larkin N, O'Connell NM, O'Mahony B, Lavin M, O'Donnell JS, Turecek PL, Gormley J, iPATH study group, 2023 May, A cross-sectional follow-up study of physical activity in adults with moderate and severe haemophilia. Haemophilia, DOI: 10.1111/hae.14775 |
O'Donnell JS, Byrne C, Preston RJS, 2023 Mar, Von Willebrand factor-inflammation crosstalk in deep vein thrombosis. J Thromb Haemost, DOI: 10.1016/j.jtha.2022.11.038 |
Lavin M, Luceros AS, Kouides P, Abdul-Kadir R, O'Donnell JS, Baker RI, Othman M, Haberichter SL, ISTH Von Willebrand Factor and Women’s Health Scientific Subcommittees, 2023 Apr, Corrigendum to Examining international practices in the management of pregnant women with von Willebrand disease [J Thromb Haemost. 2022 Jan;20(1):82-91]. J Thromb Haemost, DOI: 10.1016/j.jtha.2023.01.020 |
Karampini E, Fogarty H, Elliott S, Morrin H, Bergin C, O'Sullivan JM, Byrne M, Martin-Loeches I, Mallon PW, Curley GF, Glavey S, Baker RI, Lavin M, Preston RJS, Cheallaigh CN, Ward SE, O'Donnell JS, 2023 Feb, Endothelial cell activation, Weibel-Palade body secretion, and enhanced angiogenesis in severe COVID-19. Res Pract Thromb Haemost, DOI: 10.1016/j.rpth.2023.100085 |
O'Donnell JS, Baker RI, 2023 Feb, Low von Willebrand Disease: A Bleeding Disorder of Unknown Cause? Hamostaseologie, DOI: 10.1055/a-1980-8198 |
Elsheikh E, Lavin M, Heck LA, Larkin N, Mullaney B, Doherty D, Kennedy M, Keenan C, Guest T, O'Mahony B, Fazavana J, Fallon PG, Preston RJS, Gormley J, Ryan K, O'Connell NM, Singleton E, Byrne M, McGowan M, Roche S, Doyle M, Crowley MP, O'Shea SI, Reipert BM, Johnsen JM, Pipe SW, Di Paola J, Turecek PL, O'Donnell JS, iPATH study group, 2023 May, Heterogeneity in the half-life of factor VIII concentrate in patients with hemophilia A is due to variability in the clearance of endogenous von Willebrand factor. J Thromb Haemost, DOI: 10.1016/j.jtha.2023.01.013 |
Ward SE, Guest T, Byrne C, Lopes P, O'Sullivan JM, Doherty D, O'Connell D, Gutierrez Llaneza S, Chion A, Fazavana J, Fallon PG, Preston RJS, Johnsen JM, Pipe SW, Turecek PL, O'Donnell JS, iPATH Study Group, 2023 Apr, Macrophage Galactose Lectin Contributes to the Regulation of FVIII (Factor VIII) Clearance in Mice-Brief Report. Arterioscler Thromb Vasc Biol, DOI: 10.1161/ATVBAHA.122.317807 |
Doherty D, Grabell J, Christopherson PA, Montgomery RR, Coller BS, Lavin M, O'Donnell JS, James PD, Zimmerman Program Investigators, 2023 Apr, Variability in International Society on Thrombosis and Haemostasis-Scientific and Standardization Committee endorsed Bleeding Assessment Tool (ISTH-BAT) score with normal aging in healthy females: contributory factors and clinical significance. J Thromb Haemost, DOI: 10.1016/j.jtha.2022.11.045 |
Mancuso ME, Holstein K, O'Donnell JS, Lobet S, Klamroth R, FVIII Think Tank Study Group, 2023 Mar, Synovitis and joint health in patients with haemophilia: Statements from a European e-Delphi consensus study. Haemophilia, DOI: 10.1111/hae.14734 |
Drakeford C, Aguila S, Roche F, Hokamp K, Fazavana J, Cervantes MP, Curtis AM, Hawerkamp HC, Dhami SPS, Charles-Messance H, Hackett EE, Chion A, Ward S, Ahmad A, Schoen I, Breen E, Keane J, Murphy R, Preston RJS, O'Sullivan JM, Sheedy FJ, Fallon P, O'Donnell JS, 2022 Nov 3, von Willebrand factor links primary hemostasis to innate immunity. Nat Commun, DOI: 10.1038/s41467-022-33796-7 |
Kennedy M, Roche S, McGowan M, Singleton E, Elsheikh E, O'Donovan M, Ryan K, O'Connell NM, O'Mahony B, Lavin M, O'Donnell JS, Turecek PL, Gormley J, iPATH study group, 2023 Jan, Physical activity, physical fitness and cardiometabolic risk amongst adults with moderate and severe haemophilia. Haemophilia, DOI: 10.1111/hae.14653 |
Fogarty H, Ward SE, Townsend L, Karampini E, Elliott S, Conlon N, Dunne J, Kiersey R, Naughton A, Gardiner M, Byrne M, Bergin C, O'Sullivan JM, Martin-Loeches I, Nadarajan P, Bannan C, Mallon PW, Curley GF, Preston RJS, Rehill AM, Baker RI, Cheallaigh CN, O'Donnell JS, Irish COVID-19 Vasculopathy Study (iCVS) Investigators, 2022 Oct, Sustained VWF-ADAMTS-13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunction. J Thromb Haemost, DOI: 10.1111/jth.15830 |
Lavin M, Christopherson P, Grabell J, Abshire T, Flood V, Haberichter SL, Lillicrap D, O'Donnell JS, Montgomery RR, James PD, 2022 Oct, Longitudinal bleeding assessment in von Willebrand disease utilizing an interim bleeding score. J Thromb Haemost, DOI: 10.1111/jth.15807 |
Dhami SPS, Patmore S, Comerford C, Byrne CM, Cavanagh B, Castle J, Kirwan CC, Kenny M, Schoen I, O'Donnell JS, O'Sullivan JM, 2022 Oct, Breast cancer cells mediate endothelial cell activation, promoting von Willebrand factor release, tumor adhesion, and transendothelial migration. J Thromb Haemost, DOI: 10.1111/jth.15794 |
McKenna E, Wubben R, Isaza-Correa JM, Melo AM, Mhaonaigh AU, Conlon N, O'Donnell JS, Ní Cheallaigh C, Hurley T, Stevenson NJ, Little MA, Molloy EJ, 2022, Neutrophils in COVID-19: Not Innocent Bystanders. Front Immunol, DOI: 10.3389/fimmu.2022.864387 |
Meaney JFM, O'Donnell JS, Bridgewood C, Harbison J, McGonagle D, 2022 Jul, Perspective: The Case for Acute Large Vessel Ischemic Stroke in COVID-19 Originating Within Thrombosed Pulmonary Venules. Stroke, DOI: 10.1161/STROKEAHA.121.038056 |
Doherty D, Michelle Lavin, Byrne M, Nolan M, O'Sullivan JM, Ryan K, O'Connell NM, Haberichter SL, Christopherson PA, Di Paola J, James PD, O'Donnell JS, 2023 Feb 14, Enhanced VWF clearance in low VWF pathogenesis: limitations of the VWFpp/VWF:Ag ratio and clinical significance. Blood Adv, DOI: 10.1182/bloodadvances.2022007340 |
Sadler B, Castaman G, O'Donnell JS, 2022 May, von Willebrand disease and von Willebrand factor. Haemophilia, DOI: 10.1111/hae.14547 |
O'Regan N, Gegenbauer K, Gleeson EM, Fukudome K, O'Sullivan JM, Drakeford C, Dalton N, Chion A, Brophy TM, Smith OP, Preston RJS, O'Donnell JS, 2022 Aug 1, Hemostatic and protein C pathway dysfunction in the pathogenesis of experimental cerebral malaria. Haematologica, DOI: 10.3324/haematol.2021.280450 |
Trinh DN, Gardner RA, Franciosi AN, McCarthy C, Keane MP, Soliman MG, O'Donnell JS, Meleady P, Spencer DIR, Monopoli MP, 2022 Apr 26, Nanoparticle Biomolecular Corona-Based Enrichment of Plasma Glycoproteins for N-Glycan Profiling and Application in Biomarker Discovery. ACS Nano, DOI: 10.1021/acsnano.1c09564 |
Kennedy M, O' Mahony B, Roche S, McGowan M, Singleton E, Ryan K, O' Connell NM, Pipe SW, Lavin M, O' Donnell JS, Turecek PL, Gormley J, on behalf of the iPATH study group, 2022 Jun, Pain and functional disability amongst adults with moderate and severe haemophilia from the Irish personalised approach to the treatment of haemophilia (iPATH) study. Eur J Haematol, DOI: 10.1111/ejh.13763 |
Kalot MA, Husainat N, Abughanimeh O, Diab O, El Alayli A, Tayiem S, Madoukh B, Dimassi A, Qureini A, Ameer B, Eikenboom J, Giraud N, Haberichter S, Jacobs-Pratt V, Konkle BA, McRae S, Montgomery R, O'Donnell JS, Brignardello-Petersen R, Flood V, Connell NT, James P, Mustafa RA, 2022 Jun 28, Laboratory assays of VWF activity and use of desmopressin trials in the diagnosis of VWD: a systematic review and meta-analysis. Blood Adv, DOI: 10.1182/bloodadvances.2021005431 |
O'Donnell AS, Fazavana J, O'Donnell JS, 2022 Jan, The von Willebrand factor - ADAMTS-13 axis in malaria. Res Pract Thromb Haemost, DOI: 10.1002/rth2.12641 |
Musgrave KM, Power K, Laffan M, O'Donnell JS, Thachil J, Maraveyas A, 2022 Mar, Practical treatment guidance for cancer-associated thrombosis - Managing the challenging patient: A consensus statement. Crit Rev Oncol Hematol, DOI: 10.1016/j.critrevonc.2022.103599 |
McGonagle D, Kearney MF, O'Regan A, O'Donnell JS, Quartuccio L, Watad A, Bridgewood C, 2022 Feb, Therapeutic implications of ongoing alveolar viral replication in COVID-19. Lancet Rheumatol, DOI: 10.1016/S2665-9913(21)00322-2 |
Fogarty H, Karampini E, O'Donnell AS, Ward SE, O'Sullivan JM, O'Donnell JS, Irish COVID-19 Vasculopathy Study (iCVS) investigators, 2022 Jan, Persistent endotheliopathy in the pathogenesis of long COVID syndrome - Reply to comment from von Meijenfeldt et al. J Thromb Haemost, DOI: 10.1111/jth.15578 |
O'Donovan M, Quinn E, Johnston K, Singleton E, Benson J, O'Mahony B, Noone D, Duggan C, Gilmore R, Ryan K, O'Donnell JS, O'Connell NM, Mahlangu J, 2021 Oct, Recombinant factor IX-Fc fusion protein in severe hemophilia B: Patient-reported outcomes and health-related quality of life. Res Pract Thromb Haemost, DOI: 10.1002/rth2.12602 |
Lavin M, Sánchez Luceros A, Kouides P, Abdul-Kadir R, O'Donnell JS, Baker RI, Othman M, Haberichter SL, ISTH Von Willebrand Factor and Women’s Health Scientific Subcommittees, 2022 Jan, Examining international practices in the management of pregnant women with von Willebrand disease. J Thromb Haemost, DOI: 10.1111/jth.15561 |
O'Donovan M, Singleton E, Roche S, McGowan M, Benson J, Bergin C, Bird R, Byrne M, Duggan C, Gilmore R, Ryan K, Dougall A, O'Donnell JS, O'Connell NM, 2021 Nov, Single centre, real-world experience of perioperative rFIXFc use in adult patients with haemophilia B undergoing major and minor surgery. Haemophilia, DOI: 10.1111/hae.14426 |
Kalot MA, Husainat N, El Alayli A, Abughanimeh O, Diab O, Tayiem S, Madoukh B, Dimassi AB, Qureini A, Ameer B, Eikenboom JCJ, Giraud N, McLintock C, McRae S, Montgomery RR, O'Donnell JS, Scappe N, Sidonio RF, Brignardello-Petersen R, Flood VH, Connell NT, James PD, Mustafa RA, 2022 Jan 11, von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis. Blood Adv, DOI: 10.1182/bloodadvances.2021005430 |
Kalot MA, Husainat N, Tayiem S, El Alayli A, Dimassi AB, Diab O, Abughanimeh O, Madoukh B, Qureini A, Ameer B, Di Paola J, Eikenboom JCJ, Jacobs-Pratt V, McLintock C, Montgomery R, O'Donnell JS, Sidonio R, Brignardello-Petersen R, Flood V, Connell NT, James PD, Mustafa RA, 2021 Dec 14, Bleeding assessment tools in the diagnosis of VWD in adults and children: a systematic review and meta-analysis of test accuracy. Blood Adv, DOI: 10.1182/bloodadvances.2021004368 |
Baker RI, O'Donnell JS, 2021 Nov 11, How I treat bleeding disorder of unknown cause. Blood, DOI: 10.1182/blood.2020010038 |
Thomas W, Downes K, Evans G, Gidley G, Lowe G, MacDonald S, Obaji S, O'Donnell JS, Palmer B, Pinto F, Desborough M, 2021 Nov, Current practice and registration patterns among United Kingdom Haemophilia Centre Doctors' Organisation centers for patients with unclassified bleeding disorders. J Thromb Haemost, DOI: 10.1111/jth.15492 |
Fogarty H, Townsend L, Morrin H, Ahmad A, Comerford C, Karampini E, Englert H, Byrne M, Bergin C, O'Sullivan JM, Martin-Loeches I, Nadarajan P, Bannan C, Mallon PW, Curley GF, Preston RJS, Rehill AM, McGonagle D, Ni Cheallaigh C, Baker RI, Renné T, Ward SE, O'Donnell JS, Irish COVID-19 Vasculopathy Study (iCVS) investigators, 2021 Oct, Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost, DOI: 10.1111/jth.15490 |
Krishnaswamy S, Ageno W, Arabi Y, Barbui T, Cannegieter S, Carrier M, Cleuren AC, Collins P, Panicot-Dubois L, Freedman JE, Freson K, Hogg P, James AH, Kretz CA, Lavin M, Leebeek FWG, Li W, Maas C, Machlus K, Makris M, Martinelli I, Medved L, Neerman-Arbez M, O'Donnell JS, O'Sullivan J, Rajpurkar M, Schroeder V, Spiegel PC Jr, Stanworth SJ, Green L, Undas A, 2021 Jul, Illustrated State-of-the-Art Capsules of the ISTH 2020 Congress. Res Pract Thromb Haemost, DOI: 10.1002/rth2.12532 |
Bakeer N, Dover S, Babyn P, Feldman BM, von Drygalski A, Doria AS, Ignas DM, Abad A, Bailey C, Beggs I, Chang EY, Dunn A, Funk S, Gibikote S, Goddard N, Hilliard P, Keshava SN, Kruse-Jarres R, Li Y, Lobet S, Manco-Johnson M, Martinoli C, O'Donnell JS, Papakonstantinou O, Pergantou H, Poonnoose P, Querol F, Srivastava A, Steiner B, Strike K, Timmer M, Tyrrell PN, Vidarsson L, Blanchette VS, 2021 Jul, Musculoskeletal ultrasound in hemophilia: Results and recommendations from a global survey and consensus meeting. Res Pract Thromb Haemost, DOI: 10.1002/rth2.12531 |
Lavin M, Elder PT, O'Keeffe D, Enright H, Ryan E, Kelly A, El Hassadi E, McNicholl FP, Benson G, Le GN, Byrne M, Ryan K, O'Connell NM, O'Donnell JS, 2021 Oct, Vaccine-induced immune thrombotic thrombocytopenia (VITT) - a novel clinico-pathological entity with heterogeneous clinical presentations. Br J Haematol, DOI: 10.1111/bjh.17613 |
Ward S, O'Sullivan JM, O'Donnell JS, 2021 Oct, The Biological Significance of von Willebrand Factor O-Linked Glycosylation. Semin Thromb Hemost, DOI: 10.1055/s-0041-1726373 |
Ward SE, Fogarty H, Karampini E, Lavin M, Schneppenheim S, Dittmer R, Morrin H, Glavey S, Ni Cheallaigh C, Bergin C, Martin-Loeches I, Mallon PW, Curley GF, Baker RI, Budde U, O'Sullivan JM, O'Donnell JS, Irish COVID-19 Vasculopathy Study (iCVS) investigators, 2021 Aug, ADAMTS13 regulation of VWF multimer distribution in severe COVID-19. J Thromb Haemost, DOI: 10.1111/jth.15409 |
O'Donnell JS, Peyvandi F, Martin-Loeches I, 2021 Aug, Pulmonary immuno-thrombosis in COVID-19 ARDS pathogenesis. Intensive Care Med, DOI: 10.1007/s00134-021-06419-w |
O'Donovan M, Bergin C, Quinn E, Singleton E, Roche S, Benson J, Bird R, Byrne M, Duggan C, Gilmore R, Ryan K, O'Donnell JS, O'Connell NM, 2021 Jul, Real-world outcomes with recombinant factor IX Fc fusion protein (rFIXFc) prophylaxis: Longitudinal follow-up in a national adult cohort. Haemophilia, DOI: 10.1111/hae.14307 |
Ward SE, O'Sullivan JM, Moran AB, Spencer DIR, Gardner RA, Sharma J, Fazavana J, Monopoli M, McKinnon TAJ, Chion A, Haberichter S, O'Donnell JS, 2022 Mar 1, Sialylation on O-linked glycans protects von Willebrand factor from macrophage galactose lectin-mediated clearance. Haematologica, DOI: 10.3324/haematol.2020.274720 |
Kennedy M, O'Gorman P, Monaghan A, Lavin M, O'Mahony B, O'Connell NM, O' Donnell JS, Turecek PL, Gormley J, Irish Personalised Approach to the Treatment of Haemophilia (iPATH) study group, 2021 Jul, A systematic review of physical activity in people with haemophilia and its relationship with bleeding phenotype and treatment regimen. Haemophilia, DOI: 10.1111/hae.14282 |
O'Donnell JS, 2021 Mar, Toward Personalized Treatment for Patients with Low von Willebrand Factor and Quantitative von Willebrand Disease. Semin Thromb Hemost, DOI: 10.1055/s-0041-1722864 |
Rehill AM, McCluskey S, O'Donnell JS, Dockal M, Preston RJS, iPATH Study Group, 2021 Mar, Heterogeneity in Bleeding Tendency and Arthropathy Development in Individuals with Hemophilia. Semin Thromb Hemost, DOI: 10.1055/s-0041-1723769 |
Townsend L, Fogarty H, Dyer A, Martin-Loeches I, Bannan C, Nadarajan P, Bergin C, O'Farrelly C, Conlon N, Bourke NM, Ward SE, Byrne M, Ryan K, O'Connell N, O'Sullivan JM, Ni Cheallaigh C, O'Donnell JS, 2021 Apr, Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase response. J Thromb Haemost, DOI: 10.1111/jth.15267 |
James PD, Connell NT, Ameer B, Di Paola J, Eikenboom J, Giraud N, Haberichter S, Jacobs-Pratt V, Konkle B, McLintock C, McRae S, R Montgomery R, O'Donnell JS, Scappe N, Sidonio R, Flood VH, Husainat N, Kalot MA, Mustafa RA, 2021 Jan 12, ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood Adv, DOI: 10.1182/bloodadvances.2020003265 |
Connell NT, James PD, Brignardello-Petersen R, Abdul-Kadir R, Ameer B, Arapshian A, Couper S, Di Paola J, Eikenboom J, Giraud N, Grow JM, Haberichter S, Jacobs-Pratt V, Konkle BA, Kouides P, Laffan M, Lavin M, Leebeek FWG, McLintock C, McRae S, Montgomery R, O'Brien SH, O'Donnell JS, Ozelo MC, Scappe N, Sidonio R, Tosetto A, Weyand AC, Kalot MA, Husainat N, Mustafa RA, Flood VH, 2021 Jan 26, von Willebrand disease: proposing definitions for future research. Blood Adv, DOI: 10.1182/bloodadvances.2020003620 |
Karampini E, O'Donnell JS, 2021 Jan, Correcting dominant-negative von Willebrand disease. J Thromb Haemost, DOI: 10.1111/jth.15123 |
Doherty D, Lavin M, O'Sullivan JM, Ryan K, O'Connell NM, Dougall A, Byrne M, Rafferty M, Doyle MM, Di Paola J, James PD, O'Donnell JS, 2021 Mar, Management of elective procedures in low von Willebrand factor patients in the LoVIC study. J Thromb Haemost, DOI: 10.1111/jth.15220 |
Ward SE, Curley GF, Lavin M, Fogarty H, Karampini E, McEvoy NL, Clarke J, Boylan M, Alalqam R, Worrall AP, Kelly C, de Barra E, Glavey S, Ni Cheallaigh C, Bergin C, Martin-Loeches I, Townsend L, Mallon PW, O'Sullivan JM, O'Donnell JS, Irish COVID-19 Vasculopathy Study (ICVS) Investigators, 2021 Feb, Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID-19): evidence of acute and sustained endothelial cell activation. Br J Haematol, DOI: 10.1111/bjh.17273 |
O'Donghaile D, Jenkins PV, McGrath RT, Preston L, Field SP, Ward SE, O'Sullivan JM, O'Donnell JS, 2020 Oct 27, Expresser phenotype determines ABO(H) blood group antigen loading on platelets and von Willebrand factor. Sci Rep, DOI: 10.1038/s41598-020-75462-2 |